Dosimetry Estimate and Initial Clinical Experience with

Adult Dipeptides Heterocyclic Compounds, 1-Ring Humans Lutetium Male Neoplasm Metastasis Phantoms, Imaging Prostate-Specific Antigen / metabolism Prostatic Neoplasms, Castration-Resistant / diagnostic imaging Radiation Protection Radioisotopes Radiometry Yttrium Radioisotopes
PSMA-617 RLT prostate cancer radiation dosimetry radionuclide therapy yttrium-90

Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 07 08 2018
accepted: 22 10 2018
pubmed: 6 11 2018
medline: 31 3 2020
entrez: 4 11 2018
Statut: ppublish

Résumé

Because of different physical properties, the β-emitters

Identifiants

DOI: 10.2967/jnumed.118.218917 PMID: 30389816
pubmed: 30389816
pii: jnumed.118.218917
doi: 10.2967/jnumed.118.218917
doi:

Substances chimiques

Dipeptides 0
Heterocyclic Compounds, 1-Ring 0
PSMA-617 0
Radioisotopes 0
Yttrium Radioisotopes 0
Yttrium-90 1K8M7UR6O1
Lutetium 5H0DOZ21UJ
Lutetium-177 BRH40Y9V1Q
Prostate-Specific Antigen EC 3.4.21.77

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

806-811

Informations de copyright

© 2019 by the Society of Nuclear Medicine and Molecular Imaging.

Auteurs

Hendrik Rathke (H)

Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany hendrik.rathke@med.uni-heidelberg.de.

Paul Flechsig (P)

Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.

Walter Mier (W)

Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.

Marcus Bronzel (M)

ABX-CRO, Dresden, Germany.

Eleni Mavriopoulou (E)

Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.

Markus Hohenfellner (M)

Department of Urology, University Hospital Heidelberg, Heidelberg, Germany.

Frederik Lars Giesel (FL)

Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.

Uwe Haberkorn (U)

Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.
Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany; and.
Translational Lung Research Center Heidelberg, German Center for Lung Research, Heidelberg, Germany.

Clemens Kratochwil (C)

Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Dosimetry Estimate and Initial Clinical Experience with
questionsmedicales.fr › Acides aminés, peptides et protéines › Peptides › Oligopeptides › Dipeptides › Dosimetry Estimate and Initial Clinical Experience with
questionsmedicales.fr › Composés hétérocycliques › Composés hétéromonocycliques › Dosimetry Estimate and Initial Clinical Experience with
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Dosimetry Estimate and Initial Clinical Experience with
questionsmedicales.fr › Produits chimiques inorganiques › Métaux › Terres rares › Lanthanides › Lutétium › Dosimetry Estimate and Initial Clinical Experience with
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Processus néoplasiques › Métastase tumorale › Dosimetry Estimate and Initial Clinical Experience with
questionsmedicales.fr › Équipement et fournitures › Fantômes en imagerie › Dosimetry Estimate and Initial Clinical Experience with
questionsmedicales.fr › Facteurs biologiques › Marqueurs biologiques › Marqueurs biologiques tumoraux › Antigène spécifique de la prostate › Dosimetry Estimate and Initial Clinical Experience with
questionsmedicales.fr › Maladies urogénitales › Tumeurs de l'appareil urogénital › Tumeurs de l'appareil génital mâle › Tumeurs de la prostate › Tumeurs prostatiques résistantes à la castration › Dosimetry Estimate and Initial Clinical Experience with
questionsmedicales.fr › Environnement et santé publique › Santé publique › Hygiène radiologique › Radioprotection › Dosimetry Estimate and Initial Clinical Experience with
questionsmedicales.fr › Produits chimiques inorganiques › Isotopes › Radio-isotopes › Dosimetry Estimate and Initial Clinical Experience with
questionsmedicales.fr › Techniques d'investigation › Radiométrie › Dosimetry Estimate and Initial Clinical Experience with
questionsmedicales.fr › Produits chimiques inorganiques › Métaux › Terres rares › Yttrium › Isotopes de l'yttrium › Radio-isotopes de l'yttrium › Dosimetry Estimate and Initial Clinical Experience with